Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1970;42:479-485

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LETH, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LETH, A.

(Circulation. 1970;42:479.)
© 1970 American Heart Association, Inc.


Changes in Plasma and Extracellular Fluid Volumes in Patients with Essential Hypertension During Long-Term Treatment with Hydrochlorothiazide

ARNE LETH M.D.1

1 From Diakonissestiftelsen, Department of Medicine, Copenhagen, Denmark.

In 13 untreated patients with essential hypertension, the plasma volume (T-1824) and the extracellular fluid volume (82Br- distribution space) were determined three times. During treatment with 50 to 100 mg of hydrochlorothiazide daily, determinations of plasma volume and extracellular fluid volume were repeated after treatment for 1 mo (13 patients), 2 mo (13 patients), 4 mo (eight patients), and 6 mo ( seven patients). In all cases the average plasma and extracellular fluid volumes were reduced compared with the averages of three control values. The plasma volume was significantly reduced at the 5% level after treatment for 1, 2, and 4 mo.

Corresponding studies from the literature have been reviewed and, on the basis of these studies and our own results, it is concluded that thiazides have a volume-depleting effect which is continued during long-term treatment of patients with essential hypertension.


Key Words: Hemoglobin • Thiazide treatment • Hematocrit

Submitted on April 3, 1970
Accepted on May 18, 1970




This article has been cited by other articles:


Home page
HypertensionHome page
G. de Simone, R. B. Devereux, M. Chinali, L. G. Best, E. T. Lee, T. K. Welty, and for the Strong Heart Study Investigators
Association of Blood Pressure With Blood Viscosity in American Indians: The Strong Heart Study
Hypertension, April 1, 2005; 45(4): 625 - 630.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. Fu, R. Zhang, S. Witkowski, A. Arbab-Zadeh, A. Prasad, K. Okazaki, and B. D. Levine
Persistent Sympathetic Activation During Chronic Antihypertensive Therapy: A Potential Mechanism for Long Term Morbidity?
Hypertension, April 1, 2005; 45(4): 513 - 521.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. S. Sharp, J. D. Curb, I. J. Schatz, H. J. Meiselman, T. C. Fisher, C. M. Burchfiel, B. L. Rodriguez, and K. Yano
Mean Red Cell Volume as a Correlate of Blood Pressure
Circulation, May 1, 1996; 93(9): 1677 - 1684.
[Abstract] [Full Text]


Home page
CirculationHome page
J. D. Parker, A. B. Parker, B. Farrell, and J. O. Parker
Effects of Diuretic Therapy on the Development of Tolerance to Nitroglycerin and Exercise Capacity in Patients With Chronic Stable Angina
Circulation, February 15, 1996; 93(4): 691 - 696.
[Abstract] [Full Text]